Literature DB >> 33350771

Altered serum levels of IL-36 cytokines (IL-36α, IL-36β, IL-36γ, and IL-36Ra) and their potential roles in Guillain-Barré syndrome.

Zhikang Zhao1, Rui Zhang1, Xinxin Gao2, Hui Li2, Hongbo Liu2.   

Abstract

ABSTRACT: Guillain-Barré syndrome (GBS) is an acute autoimmune neurological disorder mainly involving the peripheral nerves. Currently, various cytokines have been shown to be involved in the pathogenesis of GBS. Because of their similar biological structures, interleukin (IL)-36α, IL-36β, IL-36γ, and IL-36 receptor antagonist (Ra) were all renamed and collectively called IL-36 cytokines. The roles of IL-36 cytokines in GBS currently remain unclear.Forty-two patients with GBS and 32 healthy volunteers were included in our study. Serum IL-36α, β, γ, and interleukin-36 receptor antagonist (IL-36Ra) levels of patients with GBS in the acute and remission phases and healthy volunteers were measured by enzyme-linked immunosorbent assay (ELISA). In addition, we examined the serum levels of other inflammatory factors that have been shown to be involved in GBS pathogenesis, represented by IL-17 and tumor necrosis factor-α (TNF-α). Furthermore, the correlations between the serum levels of IL-36 cytokines and different clinical data or the serum levels of other inflammatory factors in GBS patients were analyzed.Significantly higher serum IL-36α and IL-36γ levels were measured in the acute phase than in the remission phase and in healthy control (HC) subjects (P < .05), while lower serum IL-36Ra levels were measured in the acute phase than in the remission phase and in HC subjects (P < .05). Serum IL-36α and IL-36γ levels were positively correlated with GBS disability scale scores (GDSs), while serum IL-36Ra levels were negatively correlated with GDSs. Correlation analyses among inflammatory factors showed that serum IL-36α and IL-36γ levels in GBS patients were positively correlated with serum IL-17 and TNF-α levels, while serum IL-36Ra levels were negatively correlated with the levels of these 2 inflammatory factors. Similar results were observed in cerebrospinal fluid (CSF), IL-36α and IL-36γ levels in CSF were positively correlated with GDSs, while IL-36Ra levels in CSF were negatively correlated with GDSs. Additionally, the serum and CSF levels of IL-36α and IL-36γ in the axonal subtype of GBS patients were higher than those in the demyelination subtype.Based on our findings, IL-36 cytokines may be involved in the pathogenesis of GBS and some of these cytokines may help predict the disease severity and other clinical characteristics of GBS.
Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33350771      PMCID: PMC7769357          DOI: 10.1097/MD.0000000000023832

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  42 in total

1.  Increased plasmacytoid dendritic cells in Guillain-Barré syndrome.

Authors:  Yu-Zhong Wang; Xun-Gang Feng; Qian Wang; Chun-Ye Xing; Qi-Guang Shi; Qing-Xia Kong; Pan-Pan Cheng; Yong Zhang; Yan-Lei Hao; Nobuhiro Yuki
Journal:  J Neuroimmunol       Date:  2015-03-27       Impact factor: 3.478

2.  Molecular determinants of agonist and antagonist signaling through the IL-36 receptor.

Authors:  Sebastian Günther; Eric J Sundberg
Journal:  J Immunol       Date:  2014-06-16       Impact factor: 5.422

Review 3.  Biology of IL-36 cytokines and their role in disease.

Authors:  Mark S Gresnigt; Frank L van de Veerdonk
Journal:  Semin Immunol       Date:  2013-12-17       Impact factor: 11.130

Review 4.  Regulation and function of interleukin-36 cytokines.

Authors:  Esen Yonca Bassoy; Jennifer E Towne; Cem Gabay
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

5.  Anti-ganglioside antibodies profile in Guillain-Barré syndrome: Correlation with clinical features, electrophysiological pattern, and outcome.

Authors:  G Sivaram Naik; A Kanikannan Meena; B Ashok Kumar Reddy; Rukmini K Mridula; Shaik A Jabeen; Rupam Borgohain
Journal:  Neurol India       Date:  2017 Sep-Oct       Impact factor: 2.117

6.  Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.

Authors:  C W Ang; M A De Klerk; H P Endtz; B C Jacobs; J D Laman; F G van der Meché; P A van Doorn
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 7.  The role of cytokines in Guillain-Barré syndrome.

Authors:  Ming-Ou Lu; Jie Zhu
Journal:  J Neurol       Date:  2010-11-23       Impact factor: 4.849

8.  Inflammatory gene expression patterns revealed by DNA microarray analysis in TNF-alpha-treated SGBS human adipocytes.

Authors:  Myoung-Sool Do; Hun-Soon Jeong; Bong-Hyuk Choi; Leif Hunter; Stuart Langley; Laszlo Pazmany; Paul Trayhurn
Journal:  Yonsei Med J       Date:  2006-10-31       Impact factor: 2.759

Review 9.  IL-36 Cytokines: Regulators of Inflammatory Responses and Their Emerging Role in Immunology of Reproduction.

Authors:  José Martin Murrieta-Coxca; Sandra Rodríguez-Martínez; Mario Eugenio Cancino-Diaz; Udo R Markert; Rodolfo R Favaro; Diana M Morales-Prieto
Journal:  Int J Mol Sci       Date:  2019-04-03       Impact factor: 5.923

Review 10.  Interleukin-36 in Infectious and Inflammatory Skin Diseases.

Authors:  Anna-Lena Buhl; Joerg Wenzel
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.